Unique ID issued by UMIN | UMIN000003171 |
---|---|
Receipt number | R000003845 |
Scientific Title | Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography. |
Date of disclosure of the study information | 2010/03/01 |
Last modified on | 2017/08/18 14:10:40 |
Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography.
PEACH trial
Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography.
PEACH trial
Japan |
Patient with dyslipidemia and with coronary artery calcification.(Agatston score 1-999)
(Patient of primary prevention of coronary heart disease)
Cardiology |
Others
NO
To investigate the effect of Pitavastatin on coronary calcification score. (compariosn with highdose treatment and combination with EPA)
Efficacy
Exploratory
Pragmatic
Not applicable
The effect of Pitavastatin on coronary calcification score. (compariosn with highdose treatment and combination with EPA)
1) The ratio of achivement of LDL-C level on Guidline.
2) Changes in TC, LDL-C, TG, HDL-C, adiponectin, fatty asid furaction, RLP-C, subfraction of HDL, hs-CRP, MCP-1, Oxdative LDL, Quantification of CD34, RBC, WBC, Hb, Ht, platelate, BNP, creatinin, BUN, uricacid, total bilirubin, AST, ALT, gamma-GTP, CK(CPK), LDH, serum Na, serum K, serum Cl, FBS, fasting insulin
3)The ratio of MACCE
4)The ratio of adverse effect
5)The relation between clinical parameter and coronary calcification score,
relation between clinical parameter and ratio of MACCE.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
YES
Institution is not considered as adjustment factor.
NO
Central registration
3
Treatment
Medicine |
Pitavastatin 2mg
Pitavastatin 4mg
Pitavastatin 2mg and EPA 1800mg
20 | years-old | <= |
Not applicable |
Male and Female
1)Dyslipidemia patient defined by guidline, or already treated by anti-dyslipidemia drugs.
2)Patient without recived PCI and CABG
3)Patient coronary CT within two months., And detected coronary artery calcification(Agatston score 1-999).
4)Over 20 years old.
1)Patient with PCI or CABG.
2)Patient can't obtained clear CT image.
3Patient without coronary artery calcification(Agatsuton score=0)
4)Patient with heaviry-calcification on coronary artery (Agatston score >=1000)
5)Patient who are favorite to treat with anti-dyslipidemia drugs other than statin.
6)Famirial hypercholesterolemia.
7)Patient corresponded contraindication of Pitavastatin.
8)Patient considered to be improper to this trial by attending doctor.
240
1st name | |
Middle name | |
Last name | Hiroshi Ito |
Okayama Univesity Graduate School of Medicine,Dentistry and Pharmaceutical Sciences
Department of Cardiovascular Medicine
2-5-1, Shikata-cho, Kita-ku, Okayama
086-235-7351
itomd@md.okayama-u.ac.jp
1st name | |
Middle name | |
Last name | Kunihisa Kohno |
Okayama Univesity hospital
Department of Cardiovascular Medicine
2-5-1, Shikata-cho, Kita-ku, Okayama
086-235-7351
kunihisakohno@msn.com
Department of Cardiovascular Medicine,
Okayama Univesity Graduate School of Medicine,Dentistry and Pharmaceutical Sciences
Japan Heart Foundation
Non profit foundation
Japan
NO
赤穂中央病院(兵庫県)、岩国医療センター(山口県)、愛媛県立中央病院(愛媛県)、岡山医療センター(岡山県)、岡山済生会総合病院(岡山県)、岡山市民病院(岡山県)、岡山赤十字病院(岡山県)、岡山大学病院(岡山県)、岡山労災病院(岡山県)、尾道市民病院(広島県)、香川県立中央病院(香川県)、笠岡第一病院(香川県)、済生会今治病院(岡山県)、済生会松山病院(愛媛県)、住友別子病院(愛媛県)、高松赤十字病院(香川県)、中国中央病院(広島県)、津山中央病院(岡山県)、鳥取市立病院(鳥取県)、久松内科循環器科(岡山県)、姫路赤十字病院(兵庫県)、福山医療センター(広島県)、福山市民病院(広島県)、福山循環器病院(広島県)、松山市民病院(愛媛県)、三豊総合病院(香川県)、屋島総合病院(香川県)
2010 | Year | 03 | Month | 01 | Day |
Published
Completed
2009 | Year | 12 | Month | 15 | Day |
2010 | Year | 05 | Month | 01 | Day |
2012 | Year | 09 | Month | 01 | Day |
2010 | Year | 02 | Month | 12 | Day |
2017 | Year | 08 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003845
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |